Curapath is a European CDMO specialized in polymer- and lipid-based non-viral drug delivery systems, supporting programs from preclinical through commercial manufacturing. The company has expertise in lipid nanoparticle (LNP) formulations, polymer excipients, and nanoparticle formulations for cell and gene therapy applications. Curapath operates manufacturing facilities in Valencia, Spain and has offices in Cambridge, Massachusetts.
Non-viral drug delivery, lipid nanoparticles (LNP), polymer excipients, nanoparticle formulations, GMP manufacturing
2 sites worldwide
No reviews available yet.
No documents available.